Beijing, April 18, 2024 - Singclean Medical was awarded the title of national-level specialized and new "Little Giant" enterprise. This honor commends Singclean Medical for its professionalism, innovation, production strength, and product uniqueness in the medical field. contribute.

As a leading company focusing on the field of medical devices, Singclean Medical has established a good reputation in the industry for its excellent professionalism. The company has a high-quality R&D team that is constantly committed to innovation and breakthroughs in medical technology. Through cooperation with top domestic and foreign scientific research institutions, Singclean Medical has achieved a series of important results in the field of medical devices and biological products, injecting new vitality into the development of the industry.
In terms of product innovation, Singclean Medical has always adhered to the concept of "market demand as the guide and technological innovation as the driving force" and continuously launched high-quality products that meet clinical needs. Its products cover many fields, including biomedical sodium hyaluronate gel, tissue engineering, etc., among which there are many domestically leading and international-level technical products. These products are not only highly recognized in the domestic market, but also sold overseas, winning a wide range of international markets.
Singclean Medical has advanced production equipment and a strict quality management system to ensure product quality and stability. The company always adheres to the principle of "quality first, service first" to provide customers with high-quality products and professional services.

Winning the title of "Little Giant" enterprise is an affirmation and encouragement for Singclean Medical's unremitting efforts over the years. In the future, Singclean Medical will continue to be committed to the innovation and development of medical technology, make greater contributions to protecting people's health, and help China's medical industry move to new heights.
-
singclean | 2024-04-25
2026 Global Dermal Filler Trend Outlook:As the global medical aesthetics market continues to evolve, consumer and clinician demands for dermal fillers are undergoing an unprecedented paradigm shift. From the early days of "blind filling and chasing volume" to today's focus on "anatomical refinement, natural facial dynamics, and ultimate comfort," the industry has officially entered the Hyaluronic Acid 4.0 Era. In this transformation driven by safety, comfort, longevity, and natural results, innovative Chinese brands like Singderm® are accelerating their breakthrough into the premium global aesthetics landscape, powered by proprietary technologies and rigorous international standards. -
singclean | 2024-04-25
Dual-Exhibition Global Layout! Singclean Medical to Showcase Premium Biomaterials and IVD Innovations at WHX Miami & WHX Bangkok 2026With the rapid advancement and technical iteration of the global healthcare industry, international presence has become the core engine for the sustainable growth of leading medical device enterprises. Hangzhou Singclean Medical Products Co., Ltd. (Singclean Medical), a globally recognized leader in medical biomaterials and In Vitro Diagnostics (IVD), has announced its upcoming participation in two world-class healthcare exhibitions from June to July 2026: WHX Miami (World Health Expo Miami 2026) in the United States and WHX Bangkok (World Health Expo Bangkok 2026) in Thailand. Singclean Medical will seize these opportunities to demonstrate its latest achievements under the dual-wheel drive of "Medical Biomaterials" and "In Vitro Diagnostics," cordially inviting global partners to explore new horizons in medical healthcare. -
singclean | 2024-04-25
Singclean Medical Shines at Mevos 2026 with Two New Singfiller Products, Ushering in a New Decade of Precision Filling